CLOPIVAS 75

Clopivas 75 Tablet is classified as an antiplatelet agent, commonly referred to as a blood thinner, which plays a crucial role in the prevention of dangerous blood clots within the vascular system. By inhibiting clot formation, this medication significantly reduces the risk of serious cardiovascular events, such as heart attacks and strokes. It is frequently prescribed for individuals who are identified as being at elevated risk for heart-related issues. This includes patients suffering from peripheral vascular disease, which involves compromised blood flow due to narrowed arteries, recent incidents of heart attack or stroke, and individuals with arrhythmias. Additionally, those who have undergone certain cardiac procedures, such as stenting, may also be prescribed this medication. Furthermore, Clopivas 75 Tablet can be administered alongside other medications during the management of heart attacks and specific types of chest pain related to heart problems, such as unstable angina. The tablet can be ingested regardless of meals and is best taken consistently at the same time each day. It is vital to adhere to the prescribed regimen, even if one feels asymptomatic, as discontinuation may elevate the risk for heart attacks or strokes. Patients should be aware that bleeding is a prevalent side effect; this may manifest as bruising, epistaxis, melena, or exacerbated menstrual bleeding. Should any bleeding episodes occur, particularly if they are severe or prolonged, it is advisable to seek immediate medical advice. This medication is contraindicated for individuals who are experiencing active bleeding, such as from a peptic ulcer or intracranial hemorrhage. Disclose any history of bleeding disorders, recent severe injuries, or surgeries to your healthcare provider, as this may necessitate temporary cessation prior to any scheduled surgical or dental interventions.